CAS: 1181226-02-7
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 4-((3,5-Dichloro-2-hydroxybenzyl)amino)-2-hydroxybenzoic acid REF: IN-DA008TPQCAS: 1181226-02-7 | 98% | A consultar | Jue 16 Ene 25 |
 | ZL006 REF: TM-T17293CAS: 1181226-02-7 | 98.29% | 38,00 €~1.095,00 € | Jue 23 Ene 25 |
 | ZL006 REF: 3D-GXB22602CAS: 1181226-02-7 | Min. 95% | A consultar | Jue 27 Feb 25 |
4-((3,5-Dichloro-2-hydroxybenzyl)amino)-2-hydroxybenzoic acid
CAS:1181226-02-7
Fórmula:
C14H11Cl2NO4
Pureza:
98%
Forma y color:
Solid
Peso molecular:
328.1474
Ref: IN-DA008TPQ
| 5mg | 160,00 € | ||
| 10mg | 180,00 € | ||
| 25mg | 476,00 € | ||
| 50mg | 525,00 € | ||
| 100mg | A consultar | ||
| 250mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 16 de Enero de 2025
ZL006
CAS:1181226-02-7
ZL006 is an effective inhibitor of nNOS/PSD-95 interaction. ZL006 also inhibits NMDA receptor-mediated NO synthesis.
Fórmula:
C14H11Cl2NO4
Pureza:
98.29%
Forma y color:
Solid
Peso molecular:
328.15
Ref: TM-T17293
| 5mg | 52,00 € | ||
| 10mg | 68,00 € | ||
| 25mg | 118,00 € | ||
| 50mg | 181,00 € | ||
| 100mg | 309,00 € | ||
| 200mg | 446,00 € | ||
| 1mL*10mM (DMSO) | 53,00 € |
Entrega estimada en Estados Unidos, el Jueves 23 de Enero de 2025
ZL006
CAS:1181226-02-7
ZL006 is a potential drug target that has been shown to inhibit the activity of …
Fórmula:
C14H11Cl2NO4
Pureza:
Min. 95%
Peso molecular:
328.15 g/mol
Ref: 3D-GXB22602
| 50mg | 1.084,00 € | ||
| 100mg | 1.508,00 € |
Entrega estimada en Estados Unidos, el Jueves 27 de Febrero de 2025
